CanSinoBIO Reports Nine-Month Revenue Growth
CanSino Biologics reported revenue of approximately RMB 882 million for the nine months ended September 30, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.